Home » Authors » CenterWatch Staff

Articles by CenterWatch Staff

Genpact to acquire Pharmalink Consulting

April 25, 2014

CenterWatch Staff

Hydra Biosciences, Boehringer Ingelheim to collaboration worldwide

April 25, 2014

CenterWatch Staff

Zimmer Holdings to combine with Biomet for $13.35B

April 25, 2014

CenterWatch Staff

Celgene acquires Crohn's disease product from Nogra Pharma for $710M

April 25, 2014

CenterWatch Staff

Michael S. Gordon named medical director for cancer center trials at Scottsdale Healthcare

April 25, 2014

CenterWatch Staff

Michael Tansey joins PhESi as strategic partner

April 24, 2014

CenterWatch Staff

FDA approves Sylvant for rare Castleman’s disease

April 24, 2014

CenterWatch Staff

HemoShear, Medivir in R&D collaboration

April 24, 2014

CenterWatch Staff

Al Jalila Foundation offers $2.2M in grants for research in UAE

April 24, 2014

CenterWatch Staff

Crown Bioscience, Shin Nippon Biomedical Laboratories partner

April 24, 2014

CenterWatch Staff

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here

Articles by CenterWatch Staff

Genpact to acquire Pharmalink Consulting

Hydra Biosciences, Boehringer Ingelheim to collaboration worldwide

Zimmer Holdings to combine with Biomet for $13.35B

Celgene acquires Crohn's disease product from Nogra Pharma for $710M

Michael S. Gordon named medical director for cancer center trials at Scottsdale Healthcare

Michael Tansey joins PhESi as strategic partner

FDA approves Sylvant for rare Castleman’s disease

HemoShear, Medivir in R&D collaboration

Al Jalila Foundation offers $2.2M in grants for research in UAE

Crown Bioscience, Shin Nippon Biomedical Laboratories partner

Featured Products

Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Best Practices for Clinical Trial Site Management

Featured Stories

Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

Ask the Experts: Applying Quality by Design to Protocols

Clinical Trials Need Greater Representation of Obese Patients, Experts Say

FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.